This suggests that negative regulation of EphB2 signaling in CRC may be a direct pathogenetic mechanism that leading to loss of tissue architecture and conferring tumor advantages in invasion and metastasis (5, 9) (Table 1). The gene discussed is EPHB2; the disease is neoplasm.